These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12825943)

  • 1. Nuclear hormone receptor targeted virtual screening.
    Schapira M; Abagyan R; Totrov M
    J Med Chem; 2003 Jul; 46(14):3045-59. PubMed ID: 12825943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
    J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coactivator LXXLL nuclear receptor recognition motif.
    Savkur RS; Burris TP
    J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor drug discovery.
    Chen T
    Curr Opin Chem Biol; 2008 Aug; 12(4):418-26. PubMed ID: 18662801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities among receptor pockets and among compounds: analysis and application to in silico ligand screening.
    Fukunishi Y; Mikami Y; Nakamura H
    J Mol Graph Model; 2005 Sep; 24(1):34-45. PubMed ID: 15950507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
    Burendahl S; Treuter E; Nilsson L
    Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orphan nuclear receptors adopted by crystallography.
    Ingraham HA; Redinbo MR
    Curr Opin Struct Biol; 2005 Dec; 15(6):708-15. PubMed ID: 16263271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S; Aharon A; Ben-Moshe T; Marantz Y; Senderowitz H
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray crystallography of agonist/antagonist-bound receptors.
    Pike AC
    Methods Mol Biol; 2009; 505():51-66. PubMed ID: 19117139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational discovery of novel nuclear hormone receptor antagonists.
    Schapira M; Raaka BM; Samuels HH; Abagyan R
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1008-13. PubMed ID: 10655475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
    Popov VM; Yee WA; Anderson AC
    Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field-based comparison of ligand and coactivator binding sites of nuclear receptors.
    Wohlfahrt G; Sipilä J; Pietilä LO
    Biopolymers; 2009 Oct; 91(10):884-94. PubMed ID: 19582836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling.
    Pearce KH; Iannone MA; Simmons CA; Gray JG
    Drug Discov Today; 2004 Sep; 9(17):741-51. PubMed ID: 15450240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
    Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
    Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PREDICT modeling and in-silico screening for G-protein coupled receptors.
    Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
    Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials.
    Hoppe C; Steinbeck C; Wohlfahrt G
    J Mol Graph Model; 2006 Mar; 24(5):328-40. PubMed ID: 16260161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.